litlas
ログインアカウント作成

Volker Vallon

1995–2025 年に発表

113
論文数
19,724
被引用数
85
h 指数
110
i10 指数

被引用数

Volker Vallon の年別被引用数1997 年: 被引用 2 件1998 年: 被引用 4 件1999 年: 被引用 5 件2000 年: 被引用 13 件2001 年: 被引用 24 件2002 年: 被引用 18 件2003 年: 被引用 46 件2004 年: 被引用 65 件2005 年: 被引用 83 件2006 年: 被引用 88 件2007 年: 被引用 101 件2008 年: 被引用 119 件2009 年: 被引用 146 件2010 年: 被引用 128 件2011 年: 被引用 209 件2012 年: 被引用 173 件2013 年: 被引用 180 件2014 年: 被引用 205 件2015 年: 被引用 183 件2016 年: 被引用 232 件2017 年: 被引用 204 件2018 年: 被引用 239 件2019 年: 被引用 674 件2020 年: 被引用 889 件2021 年: 被引用 849 件2022 年: 被引用 781 件2023 年: 被引用 548 件2024 年: 被引用 847 件2025 年: 被引用 367 件2026 年: 被引用 11 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,701 件、この内訳の 24.5%中国: 引用元論文 810 件、この内訳の 11.7%ドイツ: 引用元論文 462 件、この内訳の 6.7%イギリス: 引用元論文 379 件、この内訳の 5.5%日本: 引用元論文 341 件、この内訳の 4.9%カナダ: 引用元論文 280 件、この内訳の 4%イタリア: 引用元論文 274 件、この内訳の 4%オランダ: 引用元論文 246 件、この内訳の 3.5%オーストラリア: 引用元論文 192 件、この内訳の 2.8%フランス: 引用元論文 162 件、この内訳の 2.3%デンマーク: 引用元論文 152 件、この内訳の 2.2%スイス: 引用元論文 151 件、この内訳の 2.2%
0%24.5%その他 25.7%

機関

分野

  • Medicine65%
  • Biochemistry, Genetics and Molecular Biology24.3%
  • Neuroscience3.8%
  • Nursing3.5%
  • Immunology and Microbiology1.1%
  • Environmental Science0.5%
  • その他1.8%

トピック

  • Diabetes Treatment and Management10.7%
  • Pancreatic function and diabetes6.1%
  • Chronic Kidney Disease and Diabetes5.6%
  • Ion Transport and Channel Regulation4.3%
  • Metabolism, Diabetes, and Cancer3.4%
  • Hormonal Regulation and Hypertension1.7%
  • その他68.2%

共著者

全論文

検索で開く
  1. Effects of SGLT2 Inhibitors on Kidney and Cardiovascular Function

    著者: Volker Vallon, Subodh Verma - Annual Review of Physiology 2020 被引用: 482

  2. The tubular hypothesis of nephron filtration and diabetic kidney disease

    著者: Volker Vallon, Scott C. Thomson - Nature Reviews Nephrology 2020 被引用: 434

  3. Metabolic Communication by SGLT2 Inhibition

    著者: A. Billing, Young Chul Kim, Søren Gullaksen, Benedikt Schrage, Janice Raabe, Arvid Hutzfeldt, Fatih Demir, Elina Kovalenko, Moritz Lassé, Aurélien Dugourd, Robin Fallegger, Birgit Klampe, Johannes Jaegers, Qing Li, Olha Kravtsova, Maria Crespo‐Masip, Amelia Palermo, Robert A. Fenton, Elion Hoxha, Stefan Blankenberg, Paulus Kirchhof, Tobias B. Huber, Esben Laugesen, Tanja Zeller, Maria Chrysopoulou, Julio Sáez-Rodríguez, Christina Magnussen, Thomas Eschenhagen, Alexander Staruschenko, Gary Siuzdak, Per Løgstrup Poulsen, Clarissa Schwab, Friederike Cuello, Volker Vallon, Markus M. Rinschen - Circulation 2023 被引用: 133

  4. Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition

    著者: Volker Vallon, Scott C. Thomson - Diabetologia 2016 被引用: 616

  5. Development of SGLT1 and SGLT2 inhibitors

    著者: Timo Rieg, Volker Vallon - Diabetologia 2018 被引用: 371

  6. A role for tubular Na+/H+exchanger NHE3 in the natriuretic effect of the SGLT2 inhibitor empagliflozin

    著者: Akira Ōnishi, Yiling Fu, Rohit Patel, Manjula Darshi, Maria Crespo‐Masip, Winnie Huang, Panai Song, Brent Freeman, Young Chul Kim, Manoocher Soleimani, Kumar Sharma, Scott C. Thomson, Volker Vallon - American Journal of Physiology-Renal Physiology 2020 被引用: 202

  7. Na+-d-glucose Cotransporter SGLT1 is Pivotal for Intestinal Glucose Absorption and Glucose-Dependent Incretin Secretion

    著者: Valentin Gorboulev, Annette Schürmann, Volker Vallon, Helmut Kipp, Alexander Jaschke, Dirk Klessen, Alexandra Friedrich, Stephan Scherneck, Timo Rieg, Robyn Cunard, Maike Veyhl-Wichmann, Aruna Srinivasan, Daniela Balen, Davorka Breljak, Rexhep Rexhepaj, Helen Parker, Fiona M. Gribble, Frank Reimann, Florian Läng, S. Wiese, Ivan Sabolić, Michael Sendtner, Hermann Koepsell - Diabetes 2011 被引用: 662

  8. The role of renal hypoxia in the pathogenesis of diabetic kidney disease: a promising target for newer renoprotective agents including SGLT2 inhibitors?

    著者: Anne C. Hesp, Jennifer A. Schaub, Pottumarthi V. Prasad, Volker Vallon, Gozewijn D. Laverman, Petter Bjornstad, Daniël H. van Raalte - Kidney International 2020 被引用: 189

  9. Probing SGLT2 as a therapeutic target for diabetes: Basic physiology and consequences

    著者: Linda A. Gallo, Ernest M. Wright, Volker Vallon - Diabetes and Vascular Disease Research 2015 被引用: 392

  10. SGLT2 Mediates Glucose Reabsorption in the Early Proximal Tubule

    著者: Volker Vallon, Kenneth A. Platt, Robyn Cunard, Jana Schroth, Jean M. Whaley, Scott C. Thomson, Hermann Koepsell, Timo Rieg - Journal of the American Society of Nephrology 2010 被引用: 561

  11. SGLT2 Inhibition and Uric Acid Excretion in Patients with Type 2 Diabetes and Normal Kidney Function

    著者: Danii L.S. Suijk, Michaël J.B. van Baar, Erik J.M. van Bommel, Zainab Iqbal, Merle M. Krebber, Volker Vallon, Daan Touw, Ewout J. Hoorn, Max Nieuwdorp, Mark M.H. Kramer, Jaap A. Joles, Petter Bjornstad, Daniël H. van Raalte - Clinical Journal of the American Society of Nephrology 2022 被引用: 94

  12. SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice

    著者: Volker Vallon, Maria Gerasimova, Michael Rose, Takahiro Masuda, Joseph Satriano, Eric Mayoux, Hermann Koepsell, Scott C. Thomson, Timo Rieg - American Journal of Physiology-Renal Physiology 2013 被引用: 477

  13. The Mechanisms and Therapeutic Potential of SGLT2 Inhibitors in Diabetes Mellitus

    著者: Volker Vallon - Annual Review of Medicine 2014 被引用: 340

  14. SGLT2 inhibition and renal urate excretion: role of luminal glucose, GLUT9, and URAT1

    著者: Aleksandra Novikov, Yiling Fu, Winnie Huang, Brent Freeman, Rohit Patel, Charlotte van Ginkel, Hermann Koepsell, Meinrad Busslinger, Akira Ōnishi, Josselin Nespoux, Volker Vallon - American Journal of Physiology-Renal Physiology 2018 被引用: 179

  15. Renal Function in Diabetic Disease Models: The Tubular System in the Pathophysiology of the Diabetic Kidney

    著者: Volker Vallon, Scott C. Thomson - Annual Review of Physiology 2011 被引用: 374

  16. Renal effects of SGLT2 inhibitors

    著者: Josselin Nespoux, Volker Vallon - Current Opinion in Nephrology & Hypertension 2019 被引用: 137

  17. Osmotic diuresis by SGLT2 inhibition stimulates vasopressin‐induced water reabsorption to maintain body fluid volume

    著者: Takahiro Masuda, Shigeaki Muto, Keiko Fukuda, Minami Watanabe, Ken Ohara, Hermann Koepsell, Volker Vallon, Daisuke Nagata - Physiological Reports 2020 被引用: 132

  18. SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation

    著者: Katherine R. Tuttle, Frank C. Brosius, Matthew A. Cavender, Paola Fioretto, Kevin Fowler, Hiddo J.L. Heerspink, Tom Manley, Darren K. McGuire, Mark E. Molitch, Amy K. Mottl, Leigh Perreault, Sylvia E. Rosas, Peter Rossing, Laura Solá, Volker Vallon, Christoph Wanner, Vlado Perkovic - American Journal of Kidney Diseases 2020 被引用: 127

  19. Effects of SGLT2 inhibitor and dietary NaCl on glomerular hemodynamics assessed by micropuncture in diabetic rats

    著者: Scott C. Thomson, Volker Vallon - American Journal of Physiology-Renal Physiology 2021 被引用: 74

  20. Knockout of Na-glucose transporter SGLT2 attenuates hyperglycemia and glomerular hyperfiltration but not kidney growth or injury in diabetes mellitus

    著者: Volker Vallon, Michael Rose, Maria Gerasimova, Joseph Satriano, Kenneth A. Platt, Hermann Koepsell, Robyn Cunard, Kumar Sharma, Scott C. Thomson, Timo Rieg - American Journal of Physiology-Renal Physiology 2012 被引用: 369

  21. Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia

    著者: Timo Rieg, Takahiro Masuda, Maria Gerasimova, Eric Mayoux, Kenneth A. Platt, David R. Powell, Scott C. Thomson, Hermann Koepsell, Volker Vallon - American Journal of Physiology-Renal Physiology 2013 被引用: 303

  22. Pathophysiology of the Diabetic Kidney

    著者: Volker Vallon, Radko Komers - Comprehensive physiology 2011 被引用: 258

  23. The proximal tubule in the pathophysiology of the diabetic kidney

    著者: Volker Vallon - American Journal of Physiology-Regulatory, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2011 被引用: 390

  24. Sodium glucose cotransporter SGLT1 as a therapeutic target in diabetes mellitus

    著者: Panai Song, Akira Ōnishi, Hermann Koepsell, Volker Vallon - Expert Opinion on Therapeutic Targets 2016 被引用: 191